Clinical observation of CAG regimen in treatment of 29 patients with hypocellular acute myelogenous leukemia
10.3760/cma.j.issn.1009-9921.2011.02.012
- VernacularTitle:CAG方案治疗低增生性急性髓系白血病29例
- Author:
Kun YA
;
Zhuogang LIU
- Publication Type:Journal Article
- Keywords:
Leukemia,myeloid,acute;
Drug therapy,combination
- From:
Journal of Leukemia & Lymphoma
2011;20(2):98-99
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinic effect of hypocellular acute myelogenous leukemia (AML) patients with CAG regimen. Methods 29 cases with hypocellular AML were treated with CAG regimen. Results There were 14 cases achieved complete remission (CR), accounting for 48.3 %; 7 cases partial remission (PR), accounting for 24.1%. The total effective rate was 72.4 %, inducing 7 cases of NR, one case dead in early time. Conclusion CAG regimen has been proved to be effective in shortening the period of reduced peripheral blood granulocytes and decreasing the death rate related to chemotherapy, hence,a secure and effective therapy in treating hypocellular AML.
